What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation.

Thumbnail Image
What does not kill you makes you stronger surviving anti cancer therapies by cytoskeletal remodeling and Myosin II reactivation.pdf (1.72 MB)
Identifiers
URI: http://hdl.handle.net/10641/2302
ISSN: 2372-3556
DOI: 10.1080/23723556.2020.1735911

Publication date

2020

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Myosin II and its regulator Rho-associated coiled-coil containing protein kinase (ROCK) are essential for cell invasion and metastatic dissemination. Our recent findings show that this molecular machinery is also involved in drug resistance in melanoma by playing a dual role: protection of tumor cells from reactive oxygen species (ROS) and DNA damage (intrinsic), and co-option of myeloid and lymphoid populations to establish immunosuppression (extrinsic).

Doctoral program

Description

Keywords

Myosin II, Cytoskeletal remodeling, Melanoma therapy resistance, Transcriptional rewiring, Immunotherapy

Citation

Collections

FACULTAD DE CIENCIAS EXPERIMENTALES